The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease.
about
Expression of the T-cell transcription factors, GATA-3 and T-bet, in the neoplastic cells of Hodgkin lymphomasEpstein-Barr virus and the origin of Hodgkin lymphomaBIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomasCluGene: A Bioinformatics Framework for the Identification of Co-Localized, Co-Expressed and Co-Regulated Genes Aimed at the Investigation of Transcriptional Regulatory Networks from High-Throughput Expression Data.Quantifying deleterious effects of regulatory variants.Hodgkin lymphoma: an update on its biology with new insights into classification.EBV in Hodgkin Lymphoma.Hodgkin's lymphoma: the pathologist's viewpointHodgkin lymphoma.Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification.Rituximab plus Ifosfamide, Carboplatin and Etoposide for T-Cell/Histiocyte-Rich B-Cell Lymphoma Arising in Nodular Lymphocyte-Predominant Hodgkin's Lymphoma.Recent insights into the biology of Hodgkin lymphoma: unraveling the mysteries of the Reed-Sternberg cell.Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma.Is Hodgkin lymphoma just another B-cell lymphoma?T cell/histiocyte-rich large B-cell lymphoma: an update on its biology and classification.Management of relapsed or refractory hodgkin lymphoma with second-generation antibody-drug conjugates: focus on brentuximab vedotin.The early transcription factor GATA-2 is expressed in classical Hodgkin's lymphoma.Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines.Nodular lymphocyte-predominant hodgkin lymphoma or T-cell/histiocyte rich large B-cell lymphoma: the problem in "grey zone" lymphomas.Mediastinal Gray Zone Lymphoma: A Wider Category Than We Think?Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms.Bob-1 is expressed in classic Hodgkin lymphoma.Loss of expression of the WNT/beta-catenin-signaling pathway transcription factors lymphoid enhancer factor-1 (LEF-1) and T cell factor-1 (TCF-1) in a subset of peripheral T cell lymphomas.T-cell/histiocyte-rich large B-cell lymphoma.Heterogeneous expression of Src tyrosine kinases Lyn, Fyn and Syk in classical Hodgkin lymphoma: prognostic implications.Intracellular signalling molecules as immunohistochemical markers of normal and neoplastic human leucocytes in routine biopsy samples.A Case of Chemotherapy-Refractory "THRLBCL like Transformation of NLPHL" Successfully Treated with Lenalidomide.The c-Jun and JunB transcription factors facilitate the transit of classical Hodgkin lymphoma tumour cells through G
P2860
Q24675877-AB603DE5-B06F-46E6-A9D5-F5919B2EDA2BQ26998999-75CD88FD-C7FF-4D16-8C7E-9FA2154E9AF2Q29622911-0C11EDE1-1AC5-47DE-A2D4-A397DA6F398CQ30653046-BF56444D-66A6-4479-A78C-0A3565F8098DQ33557469-2A2887FB-67A0-4D69-886F-2EDC6FB57B3CQ33588862-9D97E2E6-23C7-4C27-BDBD-6D225DAFAFFDQ34549468-949F697D-4A9D-43B9-A4AF-FD4D06E66AE1Q34564836-7339DC0B-759C-4DCD-99DF-14C324E1CB21Q34643277-671D7C5E-E062-4068-A05C-7F0B104C0844Q35013338-56B6C20B-DE8C-4D8F-A969-BE259E04CA09Q36206169-2EBAF650-027C-4629-9B0A-7E9E6FE16F26Q37004635-8B94F006-8E09-4119-997E-039F98E6A9CCQ37016499-FCA29019-6A79-415A-9308-23853B9A386AQ37738584-C643338B-62DD-407D-B3FD-4387D7D8E5E3Q37955807-748EBDEC-2941-4B58-9177-28CD48DFDB87Q38164572-1BF2A134-A87A-44BD-B221-59521F5082BEQ40493273-6713ABE1-B6C8-4D4B-A222-27D01FE85BF8Q40669895-838FDBB5-60F7-4BAD-BC79-933DF8D7ABC7Q40796275-6DD8D590-0544-44AC-A4B6-DE96BAA10606Q40864458-4F9C1995-AA8C-4EDA-A537-6790022B00D1Q41921960-68F164B5-B270-45CA-905B-ED64D77C353FQ41969041-9E6D8AE3-F2E3-4E4E-BD03-9C2566008615Q42854935-93D777DE-35CB-47C8-A92D-5E877BCBF864Q42879198-5824402A-CB28-4BDC-AC5B-D7C63D356450Q43872764-8D2F9C54-7FAB-453A-90E9-E73293638820Q48036231-3FDDF557-E957-47DC-BA03-F9450808748DQ53431646-BAEA6FA5-2F13-4A1D-AB4E-B73440756B0CQ58099160-21FA3440-AE29-4844-8332-5F37EF4EB529
P2860
The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
The transcription factor PU.1, ...... t classical Hodgkin's disease.
@en
type
label
The transcription factor PU.1, ...... t classical Hodgkin's disease.
@en
prefLabel
The transcription factor PU.1, ...... t classical Hodgkin's disease.
@en
P2093
P2860
P1476
The transcription factor PU.1, ...... t classical Hodgkin's disease.
@en
P2093
P2860
P304
P356
10.1016/S0002-9440(10)63027-1
P407
P50
P577
2001-11-01T00:00:00Z